Over the last 7 days, the Life Sciences industry has risen 2.1%, driven by gains from Lonza Group of 1.8%. In the past year, the industry is down 18%. Earnings are forecast to grow by 14% annually.
Has the Swiss Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 22 Mar 2023 | CHF56.4b | CHF9.7b | CHF1.7b | 41.5x | 34x | 5.8x |
Fri, 17 Feb 2023 | CHF58.0b | CHF9.6b | CHF1.6b | 33.9x | 35.5x | 6.1x |
Sun, 15 Jan 2023 | CHF53.4b | CHF9.2b | CHF1.3b | 40x | 40.2x | 5.8x |
Tue, 13 Dec 2022 | CHF51.3b | CHF9.2b | CHF1.3b | 37.8x | 38.6x | 5.6x |
Thu, 10 Nov 2022 | CHF54.6b | CHF9.2b | CHF1.3b | 42.1x | 41.1x | 5.9x |
Sat, 08 Oct 2022 | CHF51.4b | CHF9.2b | CHF1.3b | 40.7x | 39.8x | 5.6x |
Mon, 05 Sep 2022 | CHF54.4b | CHF9.2b | CHF1.3b | 42.5x | 42.1x | 5.9x |
Wed, 03 Aug 2022 | CHF57.6b | CHF8.9b | CHF1.3b | 35.1x | 43.9x | 6.5x |
Fri, 01 Jul 2022 | CHF52.3b | CHF8.5b | CHF1.1b | 42.7x | 48.5x | 6.2x |
Sun, 29 May 2022 | CHF58.5b | CHF8.5b | CHF1.1b | 47.4x | 54.2x | 6.9x |
Tue, 26 Apr 2022 | CHF61.9b | CHF8.5b | CHF1.1b | 56.6x | 57.4x | 7.3x |
Thu, 24 Mar 2022 | CHF68.1b | CHF8.3b | CHF1.1b | 50.6x | 63.1x | 8.2x |
Sat, 19 Feb 2022 | CHF63.8b | CHF8.0b | CHF1.1b | 50x | 59.7x | 8x |
Mon, 17 Jan 2022 | CHF69.6b | CHF7.4b | CHF929.4m | 72.6x | 74.9x | 9.4x |
Wed, 15 Dec 2021 | CHF77.3b | CHF7.4b | CHF918.2m | 85.4x | 84.2x | 10.5x |
Fri, 12 Nov 2021 | CHF78.6b | CHF7.4b | CHF918.9m | 71.3x | 85.5x | 10.7x |
Sun, 10 Oct 2021 | CHF75.4b | CHF7.4b | CHF919.7m | 70.3x | 82x | 10.2x |
Tue, 07 Sep 2021 | CHF82.7b | CHF7.4b | CHF920.8m | 87.5x | 89.9x | 11.2x |
Thu, 05 Aug 2021 | CHF75.4b | CHF7.4b | CHF920.8m | 61.8x | 81.9x | 10.2x |
Sun, 09 May 2021 | CHF61.1b | CHF7.1b | CHF964.3m | 60.5x | 63.4x | 8.7x |
Wed, 10 Feb 2021 | CHF55.2b | CHF6.5b | CHF972.6m | 53.9x | 56.7x | 8.5x |
Tue, 03 Nov 2020 | CHF54.0b | CHF5.4b | CHF913.9m | 57.3x | 59.1x | 10x |
Fri, 07 Aug 2020 | CHF52.6b | CHF5.3b | CHF889.3m | 56.1x | 59.2x | 9.9x |
Thu, 30 Apr 2020 | CHF40.0b | CHF5.6b | CHF858.4m | 47x | 46.6x | 7.1x |
43.9x
Which industries have driven the changes within the Swiss Healthcare industry?
CH Market | 0.63% | |
Healthcare | 0.82% | |
Life Sciences | 1.83% | |
Clinical Research and Equipment | 1.83% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LONN Lonza Group | CHF536.20 | 2.6% +CHF994.1m | -19.1% | PE32.7x | |
TECN Tecan Group | CHF394.80 | 2.3% +CHF112.1m | 12.9% | PE41.5x | |
SKAN SKAN Group | CHF69.50 | 6.6% +CHF96.7m | 8.6% | PE232.5x | |
SFZN Siegfried Holding | CHF649.50 | 0.7% +CHF42.3m | -11.2% | PE17.6x | |
XLS Xlife Sciences | CHF33.50 | 2.4% +CHF4.3m | -21.5% | PE3.7x |